Adial Pharmaceuticals
ADIL
20 hedge funds and large institutions have $5.5M invested in Adial Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
75% more capital invested
Capital invested by funds: $3.15M → $5.5M (+$2.36M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 19 → 20 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$132K |
| 2 |
Millennium Management
New York
|
+$56.5K |
| 3 |
Charles Schwab
San Francisco,
California
|
+$39.8K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$35.6K |
| 5 |
NP
NorthRock Partners
Minneapolis,
Minnesota
|
+$33.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$79K |
| 2 |
GG
Golden Green
Seneca,
South Carolina
|
-$63K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$4.19K |
| 5 |
BlackRock
New York
|
-$2.09K |
ADIL Hedge Fund Activity: Q3 2021 in Review
20 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q3 2021, worth a combined $5.5M — up 75% from $3.15M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ADIL positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $132K. The largest seller was Virtu Financial, exiting entirely with an estimated $79K sold.
- 20 institutional investors held Adial Pharmaceuticals (ADIL) as of Q3 2021, up from 19 in Q2 2021.
- Funds reported $5.5M of Adial Pharmaceuticals stock for Q3 2021, up 75% quarter-over-quarter.
- 5 funds opened new Adial Pharmaceuticals positions in Q3 2021 and 4 closed out, a net change of +1 holder.
- The largest Adial Pharmaceuticals buyer in Q3 2021 was Morgan Stanley, an estimated $132K added.
- The largest Adial Pharmaceuticals seller in Q3 2021 was Virtu Financial, an estimated $79K sold.
Based on aggregated 13F filings for Q3 2021.